［1］国家卫生健康委员会医政医管局. 脑胶质瘤诊疗规范(2018年版). 中华神经外科杂志, 2019, 35 (3): 217-239.

［2］中国脑胶质瘤协作组 (CGCG). 成人幕上低级别胶质瘤的手术治疗指南. 中华神经外科杂志, 2016, 32 (7): 652-658.

［3］中华医学会放射肿瘤治疗学分会. 胶质瘤放疗中国专家共识 (2017). 中华放射肿瘤学杂志, 2018, 27 (2): 123-131.

［4］王引言, 毛庆, 王江飞, 等. 低级别胶质瘤占位效应与术后癫痫缓解率的相关性研究. 中华神经外科杂志, 2014,30 (10): 1031-1034.

［5］BAUMERT B G, HEGI M E, VAN DEN BENT M J, et al. Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033–26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncol, 2016, 17 (11): 1521-1532.

［6］BELL E H, ZHANG P, FISHER B J, et al. Association of MGMT promoter methylation status with survival outcomes in patients with high-risk glioma treated with radiotherapy and temozolomide: an analysis from the NRG Oncology/RTOG 0424 trial. JAMA Oncol, 2018, 4 (10): 1405-1409.

［7］BUCKNER J C, SHAW E G, PUGH S L, et al. Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma. N Engl J Med, 2016, 374 (14): 1344-1355.

［8］FISHER B J, HU C, MACDONALD D R, et al. Phase 2 study of temozolomide-based chemoradiation therapy for high-risk lowgrade gliomas: preliminary results of Radiation Therapy Oncology Group 0424. Int J Radiat Oncol Biol Phys, 2015, 91 (3): 497-504.

［9］LIANG S L, FAN X, ZHAO M, et al. Clinical practice guidelines for the diagnosis and treatment of adult diffuse glioma-related epilepsy. Cancer Med, 2019, 8 (10): 4527-4535.

［10］LOUIS D N, PERRY A, REIFENBERGER G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol,2016, 131 (6): 803-820.

［11］National Comprehensive Cancer Network. NCCN clinical practice guidelines: central nervous system cancers, V. 1.2019.[2020-01-01]. https://www. nccn. org/professionals/ physician_gls/pdf/cns. pdf.

［12］SEPÚLVEDA-SÁNCHEZ J M, MUÑOZ LANGA J, ARRÁEZ M Á, et al. SEOM clinical guideline of diagnosis and management of low-grade glioma (2017). Clin Transl Oncol, 2018, 20 (1): 3-15.

［13］VAN DEN BENT M J, AFRA D, DE WITTE O, et al. Longterm efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet Lond Engl, 2005, 366 (9490): 985-990.